Kusajili – Clinical trials directory

Result of your search per sponsor: Thierry Lesimple, MD

Woman and Man Max 99 years
Thierry Lesimple, MD Update Il y a 4 ans

Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis The purpose of this study is to determine wether cobimetinib + vemurafenib combination treatment is effective in the treatment of BRAFV600-mutated melanoma patients with brain metastasis

Country France
organs None
Specialty None

Opened trial

More information